{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T04:15:12Z","timestamp":1773980112692,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s00066-019-01457-2","type":"journal-article","created":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T16:06:03Z","timestamp":1554134763000},"page":"725-733","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Re-irradiation in locally recurrent lung cancer patients","Rebestrahlung bei Lokalrezidiven von Lungenkarzinomen"],"prefix":"10.1007","volume":"195","author":[{"given":"Ingmar","family":"Schlampp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliane","family":"Rieber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Adeberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farastuk","family":"Bozorgmehr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claus Peter","family":"Heu\u00dfel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Steins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jutta","family":"Kappes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Welzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Debus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Rieken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,1]]},"reference":[{"key":"1457_CR1","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1093\/annonc\/mdw022","volume":"27","author":"M Malvezzi","year":"2016","unstructured":"Malvezzi M, Carioli G, Bertuccio P et\u00a0al (2016) European cancer mortality predictions for the year 2016 with focus on leukaemias. Ann Oncol 27:725\u2013731","journal-title":"Ann Oncol"},{"key":"1457_CR2","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.prro.2015.02.012","volume":"5","author":"G Rodrigues","year":"2015","unstructured":"Rodrigues G, Choy H, Bradley J et al (2015) Definitive radiation therapy in locally advanced non-small cell lung cancer: executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based clinical practice guideline. Pract Radiat Oncol 5:141\u2013148","journal-title":"Pract Radiat Oncol"},{"key":"1457_CR3","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1200\/JCO.2014.59.2360","volume":"33","author":"A Bezjak","year":"2015","unstructured":"Bezjak A, Temin S, Franklin G et al (2015) Definitive and adjuvant radiotherapy in locally advanced non-small-cell lung cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline. J\u00a0Clin Oncol 33:2100\u20132105","journal-title":"J Clin Oncol"},{"key":"1457_CR4","doi-asserted-by":"publisher","first-page":"4106","DOI":"10.1200\/JCO.2015.63.7918","volume":"33","author":"CM Rudin","year":"2015","unstructured":"Rudin CM, Ismaila N, Hann CL et al (2015) Treatment of small-cell lung cancer: American Society of Clinical Oncology Endorsement of the American College of Chest Physicians Guideline. J\u00a0Clin Oncol 33:4106\u20134111","journal-title":"J Clin Oncol"},{"key":"1457_CR5","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1093\/jnci\/djr325","volume":"103","author":"WJ Curran","year":"2011","unstructured":"Curran WJ, Paulus R, Langer CJ et al (2011) Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410. J\u00a0Natl Cancer Inst 103:1452\u20131460","journal-title":"J Natl Cancer Inst"},{"key":"1457_CR6","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1056\/NEJM199901283400403","volume":"340","author":"AT Turrisi","year":"1999","unstructured":"Turrisi AT, Kim K, Blum R et al (1999) Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N\u00a0Engl J Med 340:265\u2013271","journal-title":"N Engl J Med"},{"key":"1457_CR7","doi-asserted-by":"publisher","first-page":"3543","DOI":"10.1200\/JCO.2007.15.0375","volume":"26","author":"GV Scagliotti","year":"2008","unstructured":"Scagliotti GV, Parikh P, Von Pawel J et al (2008) Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. J\u00a0Clin Oncol 26:3543\u20133551","journal-title":"J Clin Oncol"},{"key":"1457_CR8","doi-asserted-by":"publisher","first-page":"e620","DOI":"10.1016\/S1470-2045(14)70345-6","volume":"15","author":"D Ruysscher De","year":"2014","unstructured":"De Ruysscher D, Faivre-finn C, Le pechoux C et al (2014) High-dose re-irradiation following radical radiotherapy for non-small-cell lung cancer. Lancet Oncol 15:e620\u2013e624","journal-title":"Lancet Oncol"},{"key":"1457_CR9","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1378\/chest.111.6.1718","volume":"111","author":"CF Mountain","year":"1997","unstructured":"Mountain CF, Dresler CM (1997) Regional lymph node classification for lung cancer staging. Chest 111:1718\u20131723","journal-title":"Chest"},{"key":"1457_CR10","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J et\u00a0al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228\u2013247","journal-title":"Eur J Cancer"},{"key":"1457_CR11","volume-title":"Common toxicity Criteria (CTC) v 4.0","author":"EORTC (European Organisation for Research and Treatment of Cancer)","year":"2009","unstructured":"EORTC (European Organisation for Research and Treatment of Cancer) (2009) Common toxicity Criteria (CTC) v 4.0. \n                              http:\/\/www.eortc.org\/investigators\/guidelines\/ctc\/"},{"key":"1457_CR12","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S1470-2045(14)71207-0","volume":"16","author":"JD Bradley","year":"2015","unstructured":"Bradley JD, Paulus R, Komaki R et al (2015) Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a\u00a0randomised, two-by-two factorial phase 3 study. Lancet Oncol 16:187\u2013199","journal-title":"Lancet Oncol"},{"key":"1457_CR13","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.ijrobp.2011.12.032","volume":"82","author":"JD Cox","year":"2012","unstructured":"Cox JD (2012) Are the results of RTOG 0617 mysterious? Int J Radiat Oncol Biol Phys 82:1042\u20131044","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1457_CR14","first-page":"75","volume":"3","author":"CS Drodge","year":"2014","unstructured":"Drodge CS, Ghosh S, Fairchild A (2014) Thoracic reirradiation for lung cancer: a\u00a0literature review and practical guide. Ann Palliat Med 3:75\u201391","journal-title":"Ann Palliat Med"},{"key":"1457_CR15","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.ijrobp.2011.01.069","volume":"80","author":"B Jeremi\u0107","year":"2011","unstructured":"Jeremi\u0107 B, Videtic GM (2011) Chest reirradiation with external beam radiotherapy for locally recurrent non-small-cell lung cancer: a\u00a0review. Int J Radiat Oncol Biol Phys 80:969\u2013977","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1457_CR16","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s10147-005-0501-1","volume":"10","author":"T Tada","year":"2005","unstructured":"Tada T, Fukuda H, Matsui K et al (2005) Non-small-cell lung cancer: reirradiation for loco-regional relapse previously treated with radiation therapy. Int J Clin Oncol 10:247\u2013250","journal-title":"Int J Clin Oncol"},{"key":"1457_CR17","first-page":"33","volume":"14","author":"R Cetingoz","year":"2009","unstructured":"Cetingoz R, Arican-alicikus Z, Nur-demiral A et al (2009) Is re-irradiation effective in symptomatic local recurrence of non small cell lung cancer patients? A single institution experience and review of the literature. J\u00a0Buon 14:33\u201340","journal-title":"J Buon"},{"key":"1457_CR18","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1097\/COC.0b013e31826b9950","volume":"37","author":"TJ Kruser","year":"2014","unstructured":"Kruser TJ, Mccabe BP, Mehta MP et al (2014) Reirradiation for locoregionally recurrent lung cancer: outcomes in small cell and non-small cell lung carcinoma. Am J Clin Oncol 37:70\u201376","journal-title":"Am J Clin Oncol"},{"key":"1457_CR19","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa1209825","volume":"368","author":"SC Darby","year":"2013","unstructured":"Darby SC, Ewertz M, Mcgale P et\u00a0al (2013) Risk of ischemic heart disease in women after radiotherapy for breast cancer. N\u00a0Engl J Med 368:987\u2013998","journal-title":"N Engl J Med"},{"key":"1457_CR20","doi-asserted-by":"publisher","first-page":"e0144211","DOI":"10.1371\/journal.pone.0144211","volume":"10","author":"X Ming","year":"2015","unstructured":"Ming X, Feng Y, Liu H et al (2015) Cardiac exposure in the dynamic conformal arc therapy, intensity-modulated radiotherapy and volumetric modulated arc therapy of lung cancer. PLoS ONE 10:e144211","journal-title":"PLoS ONE"},{"key":"1457_CR21","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.lungcan.2013.12.006","volume":"83","author":"GH Griffioen","year":"2014","unstructured":"Griffioen GH, Dahele M, De haan PF, al at (2014) High-dose, conventionally fractionated thoracic reirradiation for lung tumors. Lung Cancer 83:356\u2013362","journal-title":"Lung Cancer"},{"key":"1457_CR22","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/1097-0142(19820301)49:5<865::AID-CNCR2820490507>3.0.CO;2-H","volume":"49","author":"N Green","year":"1982","unstructured":"Green N, Melbye RW (1982) Lung cancer: retreatment of local recurrence after definitive irradiation. Cancer 49:865\u2013868","journal-title":"Cancer"},{"key":"1457_CR23","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/S0360-3016(01)02644-X","volume":"52","author":"Y Okamoto","year":"2002","unstructured":"Okamoto Y, Murakami M, Yoden E et\u00a0al (2002) Reirradiation for locally recurrent lung cancer previously treated with radiation therapy. Int J Radiat Oncol Biol Phys 52:390\u2013396","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1457_CR24","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ijrobp.2009.06.091","volume":"76","author":"LB Marks","year":"2010","unstructured":"Marks LB, Bentzen SM, Deasy JO et al (2010) Radiation dose-volume effects in the lung. Int J Radiat Oncol Biol Phys 76:70\u201376","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1457_CR25","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.radonc.2013.02.002","volume":"106","author":"JD Evans","year":"2013","unstructured":"Evans JD, Gomez DR, Amini A et\u00a0al (2013) Aortic dose constraints when reirradiating thoracic tumors. Radiother Oncol 106:327\u2013332","journal-title":"Radiother Oncol"},{"key":"1457_CR26","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.radonc.2015.09.029","volume":"117","author":"T Schytte","year":"2015","unstructured":"Schytte T, Bentzen SM, Brink C, Hansen O (2015) Changes in pulmonary function after definitive radiotherapy for NSCLC. Radiother Oncol 117:23\u201328","journal-title":"Radiother Oncol"},{"key":"1457_CR27","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.ijrobp.2004.11.029","volume":"62","author":"GR Borst","year":"2005","unstructured":"Borst GR, De jaeger K, Belderbos JS et al (2005) Pulmonary function changes after radiotherapy in non-small-cell lung cancer patients with long-term disease-free survival. Int J Radiat Oncol Biol Phys 62:639\u2013644","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1457_CR28","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S0360-3016(03)00182-2","volume":"56","author":"KL Miller","year":"2003","unstructured":"Miller KL, Zhou SM, Barrier RC et al (2003) Long-term changes in pulmonary function tests after definitive radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys 56:611\u2013615","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-019-01457-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00066-019-01457-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-019-01457-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T23:06:31Z","timestamp":1585609591000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00066-019-01457-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,1]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["1457"],"URL":"https:\/\/doi.org\/10.1007\/s00066-019-01457-2","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,1]]},"assertion":[{"value":"3 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical guidelines"}},{"value":"C.P.\u00a0Heu\u00dfel is a\u00a0stock owner of Stada and GSK and has received consultation and lecture fees and\/or honoraria from Schering-Plough, Pfizer, Basilea, Boehringer Ingelheim, Novartis, Roche, Astellas, Gilead, MSD, Lilly, Intermune, Fresenius, Olympus, Essex, AstraZeneca, Bracco, MEDA Pharma, Chiesi, Siemens, Covidien, Pierre Fabre, Grifols and Bayer and research funding from Siemens, Pfizer, MeVis and Boehringer Ingelheim. I.\u00a0Schlampp, J.\u00a0Rieber, S.\u00a0Adeberg, F.\u00a0Bozorgmehr, M.\u00a0Steins, J.\u00a0Kappes, H.\u00a0Hoffmann, T.\u00a0Welzel, J.\u00a0Debus and S.\u00a0Rieken declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All patients provided written informed consent after thorough information about treatment concepts and possible side effects. The responsible ethics committee approved the analysis.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}